Appointment of Dr. Alaka Keshav Deshpande (DIN: 11238406) as Woman Independent Director in terms of regulation 17(1A) of the SEBI (LODR) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has appointed Dr. Alaka Keshav Deshpande (DIN: 11238406) as a Woman Independent Director, effective September 27, 2025. The appointment was approved by members at the company's 52nd Annual General Meeting and is for a fixed term of three consecutive years, ending September 26, 2028. Dr. Deshpande, an MBBS and MD in General Medicine with extensive academic and clinical experience, replaces Mrs. Mangala Prabhu whose tenure ended on September 27, 2025. She is not related to any existing Director or Key Managerial Personnel and is not debarred by SEBI or any authority from holding the directorship.
This is a routine board-level succession change to comply with SEBI's requirement for a woman independent director and is unlikely to have any material impact on the stock price or business operations.